City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  George Somlo, MD  
Search results:  5  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-5 Trials Jump to page:

COH Protocol Number: 14117 ClinicalTrials.gov Number: NCT02163694

Principal Investigator: George Somlo, MD
Sponsor: Industrial

Title:  A Phase 3 Randomized, Placebo-Controlled Trial of Carboplatin and Paclitazel with or Without the PARP Inhibitor Veliparib (ABT-888) in HER2-Negative Metastatic or Locally Advanced Unresectable BRCA-Associated Breast Cancer

COH Protocol Number: 13497 ClinicalTrials.gov Number: NCT02137837

Principal Investigator: George Somlo, MD
Sponsor: Cooperative Group

Title:  SWOG S1222: Fulvestrant Alone Versus Fulvestrant and Everolimus Versus Fulvestrant, Everolimus and Anastrozole: A Phase III Randomized Placebo-Controlled Trial in Postmenopausal Patients with Hormone-Receptor Positive Stage IV Breast Cancer

COH Protocol Number: 12147 ClinicalTrials.gov Number: NCT01730833

Principal Investigator: George Somlo, MD
Sponsor: NCI Approved External Peer Review

Title:  Phase II Prospective Open Label Single Arm Study of Pertuzumab, Trastuzumab, and Nab-Paclitaxel in Patients with HER-2 Positive Advanced Breast Cancer

COH Protocol Number: 11174 ClinicalTrials.gov Number: NCT01525966

Principal Investigator: George Somlo, MD
Sponsor: Institutional

Title:  Phase II Trial of Neoadjuvant Chemotherapy with Carboplatin and NAB-Paclitaxel in Patients with Locally Advanced and Inflammatory Triple Negative Breast Cancer

COH Protocol Number: 08128 ClinicalTrials.gov Number: NCT01048918

Principal Investigator: George Somlo, MD
Sponsor: NCI Approved External Peer Review

Title:  Characterization of Circulating Tumor Cells (CTCs) to Direct Pre-Operative and Systemic Therapy in Patients with Locally Advanced or Metastatic Stage IV Breast Cancer

 
Results per page: 25 50 100 All 1-5 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.